160 related articles for article (PubMed ID: 21429439)
1. Pharmacokinetics of vancomycin in neonates admitted to the neonatology unit at the Jordan University Hospital.
Badran EF; Shamayleh A; Irshaid YM
Int J Clin Pharmacol Ther; 2011 Apr; 49(4):252-7. PubMed ID: 21429439
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
3. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates.
Leroux S; Jacqz-Aigrain E; Biran V; Lopez E; Madeleneau D; Wallon C; Zana-Taïeb E; Virlouvet AL; Rioualen S; Zhao W
Antimicrob Agents Chemother; 2016 Apr; 60(4):2039-42. PubMed ID: 26787690
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes in methicillin-resistant Staphylococcus aureus-colonized neonates in the neonatal intensive care unit.
Kim YH; Chang SS; Kim YS; Kim EA; Yun SC; Kim KS; Pi SY
Neonatology; 2007; 91(4):241-7. PubMed ID: 17568155
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin cerebrospinal fluid concentrations after intravenous administration in premature infants.
Reiter PD; Doron MW
J Perinatol; 1996; 16(5):331-5. PubMed ID: 8915929
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
Kitzis MD; Goldstein FW
Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
[TBL] [Abstract][Full Text] [Related]
9. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units.
Kadambari S; Heath PT; Sharland M; Lewis S; Nichols A; Turner MA
J Antimicrob Chemother; 2011 Nov; 66(11):2647-50. PubMed ID: 21862473
[TBL] [Abstract][Full Text] [Related]
10. [Vancomycin, what else?].
Daurel C; Leclercq R
Arch Pediatr; 2010 Sep; 17 Suppl 4():S121-8. PubMed ID: 20826319
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
[TBL] [Abstract][Full Text] [Related]
12. Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit.
Thorburn K; Taylor N; Saladi SM; van Saene HK
Clin Microbiol Infect; 2006 Jan; 12(1):35-42. PubMed ID: 16460544
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin is commonly under-dosed in critically ill children and neonates.
Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
[TBL] [Abstract][Full Text] [Related]
14. Vancomycin prescription in neonates and young infants: toward a simplified dosage.
Oudin C; Vialet R; Boulamery A; Martin C; Simon N
Arch Dis Child Fetal Neonatal Ed; 2011 Sep; 96(5):F365-70. PubMed ID: 21378399
[TBL] [Abstract][Full Text] [Related]
15. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
16. Outbreak of invasive disease caused by methicillin-resistant Staphylococcus aureus in neonates and prevalence in the neonatal intensive care unit.
Nambiar S; Herwaldt LA; Singh N
Pediatr Crit Care Med; 2003 Apr; 4(2):220-6. PubMed ID: 12749656
[TBL] [Abstract][Full Text] [Related]
17. Evolution of empiric vancomycin dosing in a neonatal population.
Radu L; Bengry T; Akierman A; Alshaikh B; Yusuf K; Dersch-Mills D
J Perinatol; 2018 Dec; 38(12):1702-1707. PubMed ID: 30341404
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates.
Mulubwa M; Griesel HA; Mugabo P; Dippenaar R; van Wyk L
Drugs R D; 2020 Jun; 20(2):105-113. PubMed ID: 32266599
[TBL] [Abstract][Full Text] [Related]
19. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Stein GE; Wells EM
Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
[TBL] [Abstract][Full Text] [Related]
20. [Preventive antibiotic administration for prevention of nosocomial septicemia in very small premature infants (VLBW infants)--preventive vancomycin administration against infections with coagulase negative streptococci--prevention of translocation with oral cefixime therapy in intestinal colonization with pathogenic gram-negative pathogens].
Möller JC; Rossa M; Nachtrodt G; Richter A; Tegtmeyer FK
Klin Padiatr; 1993; 205(3):140-4. PubMed ID: 8350584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
